Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
33,560
archived clinical trials in
Neurology

Rasagiline in Subjects With Amyotrophic Lateral Sclerosis (ALS)
Phase 2 Study of Rasagiline for Treatment of Amyotrophic Lateral Sclerosis
Status: Enrolling
Updated:  1/23/2017
California Pacific Medical Center
mi
from
San Francisco, CA
Rasagiline in Subjects With Amyotrophic Lateral Sclerosis (ALS)
Phase 2 Study of Rasagiline for Treatment of Amyotrophic Lateral Sclerosis
Status: Enrolling
Updated: 1/23/2017
California Pacific Medical Center
mi
from
San Francisco, CA
Click here to add this to my saved trials
Rasagiline in Subjects With Amyotrophic Lateral Sclerosis (ALS)
Phase 2 Study of Rasagiline for Treatment of Amyotrophic Lateral Sclerosis
Status: Enrolling
Updated:  1/23/2017
University of Kansas Medical Center
mi
from
Kansas City, KA
Rasagiline in Subjects With Amyotrophic Lateral Sclerosis (ALS)
Phase 2 Study of Rasagiline for Treatment of Amyotrophic Lateral Sclerosis
Status: Enrolling
Updated: 1/23/2017
University of Kansas Medical Center
mi
from
Kansas City, KA
Click here to add this to my saved trials
Rasagiline in Subjects With Amyotrophic Lateral Sclerosis (ALS)
Phase 2 Study of Rasagiline for Treatment of Amyotrophic Lateral Sclerosis
Status: Enrolling
Updated:  1/23/2017
St. Louis University
mi
from
St. Louis, MO
Rasagiline in Subjects With Amyotrophic Lateral Sclerosis (ALS)
Phase 2 Study of Rasagiline for Treatment of Amyotrophic Lateral Sclerosis
Status: Enrolling
Updated: 1/23/2017
St. Louis University
mi
from
St. Louis, MO
Click here to add this to my saved trials
Rasagiline in Subjects With Amyotrophic Lateral Sclerosis (ALS)
Phase 2 Study of Rasagiline for Treatment of Amyotrophic Lateral Sclerosis
Status: Enrolling
Updated:  1/23/2017
University of Nebraska
mi
from
Omaha, NE
Rasagiline in Subjects With Amyotrophic Lateral Sclerosis (ALS)
Phase 2 Study of Rasagiline for Treatment of Amyotrophic Lateral Sclerosis
Status: Enrolling
Updated: 1/23/2017
University of Nebraska
mi
from
Omaha, NE
Click here to add this to my saved trials
Rasagiline in Subjects With Amyotrophic Lateral Sclerosis (ALS)
Phase 2 Study of Rasagiline for Treatment of Amyotrophic Lateral Sclerosis
Status: Enrolling
Updated:  1/23/2017
Columbia University
mi
from
New York, NY
Rasagiline in Subjects With Amyotrophic Lateral Sclerosis (ALS)
Phase 2 Study of Rasagiline for Treatment of Amyotrophic Lateral Sclerosis
Status: Enrolling
Updated: 1/23/2017
Columbia University
mi
from
New York, NY
Click here to add this to my saved trials
Rasagiline in Subjects With Amyotrophic Lateral Sclerosis (ALS)
Phase 2 Study of Rasagiline for Treatment of Amyotrophic Lateral Sclerosis
Status: Enrolling
Updated:  1/23/2017
Oregon Health and Science University
mi
from
Portland, OR
Rasagiline in Subjects With Amyotrophic Lateral Sclerosis (ALS)
Phase 2 Study of Rasagiline for Treatment of Amyotrophic Lateral Sclerosis
Status: Enrolling
Updated: 1/23/2017
Oregon Health and Science University
mi
from
Portland, OR
Click here to add this to my saved trials
Rasagiline in Subjects With Amyotrophic Lateral Sclerosis (ALS)
Phase 2 Study of Rasagiline for Treatment of Amyotrophic Lateral Sclerosis
Status: Enrolling
Updated:  1/23/2017
Univ of Pennsylvania
mi
from
Philadelphia, PA
Rasagiline in Subjects With Amyotrophic Lateral Sclerosis (ALS)
Phase 2 Study of Rasagiline for Treatment of Amyotrophic Lateral Sclerosis
Status: Enrolling
Updated: 1/23/2017
Univ of Pennsylvania
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Rasagiline in Subjects With Amyotrophic Lateral Sclerosis (ALS)
Phase 2 Study of Rasagiline for Treatment of Amyotrophic Lateral Sclerosis
Status: Enrolling
Updated:  1/23/2017
U.T. Southwestern Medical Center
mi
from
Dallas, TX
Rasagiline in Subjects With Amyotrophic Lateral Sclerosis (ALS)
Phase 2 Study of Rasagiline for Treatment of Amyotrophic Lateral Sclerosis
Status: Enrolling
Updated: 1/23/2017
U.T. Southwestern Medical Center
mi
from
Dallas, TX
Click here to add this to my saved trials
Translational Research Examining Acupuncture Treatment in Traumatic Brain Injury
Translational Research Examining Acupuncture Treatment in Traumatic Brain Injury
Status: Enrolling
Updated:  1/23/2017
Healing Response Acupuncture & Integrative Medicine
mi
from
Dallas, TX
Translational Research Examining Acupuncture Treatment in Traumatic Brain Injury
Translational Research Examining Acupuncture Treatment in Traumatic Brain Injury
Status: Enrolling
Updated: 1/23/2017
Healing Response Acupuncture & Integrative Medicine
mi
from
Dallas, TX
Click here to add this to my saved trials
Allogeneic Human Umbilical Cord Mesenchymal Stem Cells for a Single Male Patient With Duchenne Muscular Dystrophy (DMD)
Allogeneic Transplantation of Human Umbilical Cord Mesenchymal Stem Cells (UC-MSC) for a Single Male Patient With Duchenne Muscular Dystrophy (DMD)
Status: Enrolling
Updated:  1/23/2017
Asthma and Allergy Consultants
mi
from
Wichita, KA
Allogeneic Human Umbilical Cord Mesenchymal Stem Cells for a Single Male Patient With Duchenne Muscular Dystrophy (DMD)
Allogeneic Transplantation of Human Umbilical Cord Mesenchymal Stem Cells (UC-MSC) for a Single Male Patient With Duchenne Muscular Dystrophy (DMD)
Status: Enrolling
Updated: 1/23/2017
Asthma and Allergy Consultants
mi
from
Wichita, KA
Click here to add this to my saved trials
The Safety and Biological Activity of ATYR1940 in Patients With Limb Girdle or Facioscapulohumeral Muscular Dystrophies
An Open-Label, Intrapatient Dose Escalation Study to Evaluate the Safety, Tolerability, Immunogenicity, and Biological Activity of ATYR1940 in Patients With Limb Girdle and Facioscapulohumeral Muscular Dystrophies
Status: Enrolling
Updated:  1/25/2017
University of California, Irvine, ALS and Neuromuscular Center
mi
from
Irvine, CA
The Safety and Biological Activity of ATYR1940 in Patients With Limb Girdle or Facioscapulohumeral Muscular Dystrophies
An Open-Label, Intrapatient Dose Escalation Study to Evaluate the Safety, Tolerability, Immunogenicity, and Biological Activity of ATYR1940 in Patients With Limb Girdle and Facioscapulohumeral Muscular Dystrophies
Status: Enrolling
Updated: 1/25/2017
University of California, Irvine, ALS and Neuromuscular Center
mi
from
Irvine, CA
Click here to add this to my saved trials
The Safety and Biological Activity of ATYR1940 in Patients With Limb Girdle or Facioscapulohumeral Muscular Dystrophies
An Open-Label, Intrapatient Dose Escalation Study to Evaluate the Safety, Tolerability, Immunogenicity, and Biological Activity of ATYR1940 in Patients With Limb Girdle and Facioscapulohumeral Muscular Dystrophies
Status: Enrolling
Updated:  1/25/2017
Kennedy Krieger Institute; The Johns Hopkins University School of Medicine
mi
from
Baltimore, MD
The Safety and Biological Activity of ATYR1940 in Patients With Limb Girdle or Facioscapulohumeral Muscular Dystrophies
An Open-Label, Intrapatient Dose Escalation Study to Evaluate the Safety, Tolerability, Immunogenicity, and Biological Activity of ATYR1940 in Patients With Limb Girdle and Facioscapulohumeral Muscular Dystrophies
Status: Enrolling
Updated: 1/25/2017
Kennedy Krieger Institute; The Johns Hopkins University School of Medicine
mi
from
Baltimore, MD
Click here to add this to my saved trials
The Safety and Biological Activity of ATYR1940 in Patients With Limb Girdle or Facioscapulohumeral Muscular Dystrophies
An Open-Label, Intrapatient Dose Escalation Study to Evaluate the Safety, Tolerability, Immunogenicity, and Biological Activity of ATYR1940 in Patients With Limb Girdle and Facioscapulohumeral Muscular Dystrophies
Status: Enrolling
Updated:  1/25/2017
OSU Wexner Medical Center
mi
from
Columbus, OH
The Safety and Biological Activity of ATYR1940 in Patients With Limb Girdle or Facioscapulohumeral Muscular Dystrophies
An Open-Label, Intrapatient Dose Escalation Study to Evaluate the Safety, Tolerability, Immunogenicity, and Biological Activity of ATYR1940 in Patients With Limb Girdle and Facioscapulohumeral Muscular Dystrophies
Status: Enrolling
Updated: 1/25/2017
OSU Wexner Medical Center
mi
from
Columbus, OH
Click here to add this to my saved trials
The Safety and Biological Activity of ATYR1940 in Patients With Limb Girdle or Facioscapulohumeral Muscular Dystrophies
An Open-Label, Intrapatient Dose Escalation Study to Evaluate the Safety, Tolerability, Immunogenicity, and Biological Activity of ATYR1940 in Patients With Limb Girdle and Facioscapulohumeral Muscular Dystrophies
Status: Enrolling
Updated:  1/25/2017
Rigshospitalet, University of Copenhagen
mi
from
Copenhagen,
The Safety and Biological Activity of ATYR1940 in Patients With Limb Girdle or Facioscapulohumeral Muscular Dystrophies
An Open-Label, Intrapatient Dose Escalation Study to Evaluate the Safety, Tolerability, Immunogenicity, and Biological Activity of ATYR1940 in Patients With Limb Girdle and Facioscapulohumeral Muscular Dystrophies
Status: Enrolling
Updated: 1/25/2017
Rigshospitalet, University of Copenhagen
mi
from
Copenhagen,
Click here to add this to my saved trials
Follow up Study of Diaphragm Pacing for Patients With High Tetraplegia
Long-term Follow-up of Patients With Ventilatory Dependent High Tetraplegia Managed With Diaphragmatic Pacing Systems
Status: Enrolling
Updated:  1/30/2017
Craig Hospital
mi
from
Englewood, CO
Follow up Study of Diaphragm Pacing for Patients With High Tetraplegia
Long-term Follow-up of Patients With Ventilatory Dependent High Tetraplegia Managed With Diaphragmatic Pacing Systems
Status: Enrolling
Updated: 1/30/2017
Craig Hospital
mi
from
Englewood, CO
Click here to add this to my saved trials
Staccato® Alprazolam and EEG Photoparoxysmal Response
Assessment of Staccato® Alprazolam on the EEG Photoparoxysmal Response in Patients With Epilepsy
Status: Enrolling
Updated:  1/30/2017
Consultants in Epilepsy and Neurology, PLLC
mi
from
Boise, ID
Staccato® Alprazolam and EEG Photoparoxysmal Response
Assessment of Staccato® Alprazolam on the EEG Photoparoxysmal Response in Patients With Epilepsy
Status: Enrolling
Updated: 1/30/2017
Consultants in Epilepsy and Neurology, PLLC
mi
from
Boise, ID
Click here to add this to my saved trials
Staccato® Alprazolam and EEG Photoparoxysmal Response
Assessment of Staccato® Alprazolam on the EEG Photoparoxysmal Response in Patients With Epilepsy
Status: Enrolling
Updated:  1/30/2017
New York University Epilepsy Center
mi
from
New York, NY
Staccato® Alprazolam and EEG Photoparoxysmal Response
Assessment of Staccato® Alprazolam on the EEG Photoparoxysmal Response in Patients With Epilepsy
Status: Enrolling
Updated: 1/30/2017
New York University Epilepsy Center
mi
from
New York, NY
Click here to add this to my saved trials
Staccato® Alprazolam and EEG Photoparoxysmal Response
Assessment of Staccato® Alprazolam on the EEG Photoparoxysmal Response in Patients With Epilepsy
Status: Enrolling
Updated:  1/30/2017
University of Pennsylvania - Penn Epilepsy Center
mi
from
Philadelphia, PA
Staccato® Alprazolam and EEG Photoparoxysmal Response
Assessment of Staccato® Alprazolam on the EEG Photoparoxysmal Response in Patients With Epilepsy
Status: Enrolling
Updated: 1/30/2017
University of Pennsylvania - Penn Epilepsy Center
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Brain Injury Biomarkers in the General Population
Status: Enrolling
Updated:  1/30/2017
Office of Nagi S. Ibrahim
mi
from
Vista, CA
Brain Injury Biomarkers in the General Population
Status: Enrolling
Updated: 1/30/2017
Office of Nagi S. Ibrahim
mi
from
Vista, CA
Click here to add this to my saved trials
Brain Injury Biomarkers in the General Population
Status: Enrolling
Updated:  1/30/2017
Shands at University Florida Gainesville
mi
from
Gainesville, FL
Brain Injury Biomarkers in the General Population
Status: Enrolling
Updated: 1/30/2017
Shands at University Florida Gainesville
mi
from
Gainesville, FL
Click here to add this to my saved trials
Brain Injury Biomarkers in the General Population
Status: Enrolling
Updated:  1/30/2017
Dekalb Medical Center
mi
from
Decatur, GA
Brain Injury Biomarkers in the General Population
Status: Enrolling
Updated: 1/30/2017
Dekalb Medical Center
mi
from
Decatur, GA
Click here to add this to my saved trials
Brain Injury Biomarkers in the General Population
Status: Enrolling
Updated:  1/30/2017
Gwinnett Medical Center
mi
from
Lawrenceville, GA
Brain Injury Biomarkers in the General Population
Status: Enrolling
Updated: 1/30/2017
Gwinnett Medical Center
mi
from
Lawrenceville, GA
Click here to add this to my saved trials
Brain Injury Biomarkers in the General Population
Status: Enrolling
Updated:  1/30/2017
New England Center for Clinical Research
mi
from
Fall River, MA
Brain Injury Biomarkers in the General Population
Status: Enrolling
Updated: 1/30/2017
New England Center for Clinical Research
mi
from
Fall River, MA
Click here to add this to my saved trials
Safety and Efficacy Study of IPX159 in Restless Legs Syndrome (RLS)
A Randomized, Double-Blind, Placebo-Controlled Safety and Efficacy Study of IPX159 in the Treatment of Moderate to Severe Restless Legs Syndrome (RLS)
Status: Enrolling
Updated:  1/31/2017
University of Alabama at Birmingham
mi
from
Brimingham, AL
Safety and Efficacy Study of IPX159 in Restless Legs Syndrome (RLS)
A Randomized, Double-Blind, Placebo-Controlled Safety and Efficacy Study of IPX159 in the Treatment of Moderate to Severe Restless Legs Syndrome (RLS)
Status: Enrolling
Updated: 1/31/2017
University of Alabama at Birmingham
mi
from
Brimingham, AL
Click here to add this to my saved trials
Safety and Efficacy Study of IPX159 in Restless Legs Syndrome (RLS)
A Randomized, Double-Blind, Placebo-Controlled Safety and Efficacy Study of IPX159 in the Treatment of Moderate to Severe Restless Legs Syndrome (RLS)
Status: Enrolling
Updated:  1/31/2017
Preferred Research Partners, Inc.
mi
from
Little Rock, AR
Safety and Efficacy Study of IPX159 in Restless Legs Syndrome (RLS)
A Randomized, Double-Blind, Placebo-Controlled Safety and Efficacy Study of IPX159 in the Treatment of Moderate to Severe Restless Legs Syndrome (RLS)
Status: Enrolling
Updated: 1/31/2017
Preferred Research Partners, Inc.
mi
from
Little Rock, AR
Click here to add this to my saved trials
Safety and Efficacy Study of IPX159 in Restless Legs Syndrome (RLS)
A Randomized, Double-Blind, Placebo-Controlled Safety and Efficacy Study of IPX159 in the Treatment of Moderate to Severe Restless Legs Syndrome (RLS)
Status: Enrolling
Updated:  1/31/2017
Scripps Clinic
mi
from
La Jolla, CA
Safety and Efficacy Study of IPX159 in Restless Legs Syndrome (RLS)
A Randomized, Double-Blind, Placebo-Controlled Safety and Efficacy Study of IPX159 in the Treatment of Moderate to Severe Restless Legs Syndrome (RLS)
Status: Enrolling
Updated: 1/31/2017
Scripps Clinic
mi
from
La Jolla, CA
Click here to add this to my saved trials
Safety and Efficacy Study of IPX159 in Restless Legs Syndrome (RLS)
A Randomized, Double-Blind, Placebo-Controlled Safety and Efficacy Study of IPX159 in the Treatment of Moderate to Severe Restless Legs Syndrome (RLS)
Status: Enrolling
Updated:  1/31/2017
Collaborative Neuroscience Network, Inc.
mi
from
Long Beach, CA
Safety and Efficacy Study of IPX159 in Restless Legs Syndrome (RLS)
A Randomized, Double-Blind, Placebo-Controlled Safety and Efficacy Study of IPX159 in the Treatment of Moderate to Severe Restless Legs Syndrome (RLS)
Status: Enrolling
Updated: 1/31/2017
Collaborative Neuroscience Network, Inc.
mi
from
Long Beach, CA
Click here to add this to my saved trials
Safety and Efficacy Study of IPX159 in Restless Legs Syndrome (RLS)
A Randomized, Double-Blind, Placebo-Controlled Safety and Efficacy Study of IPX159 in the Treatment of Moderate to Severe Restless Legs Syndrome (RLS)
Status: Enrolling
Updated:  1/31/2017
Research Center of Southern California
mi
from
Oceanside, CA
Safety and Efficacy Study of IPX159 in Restless Legs Syndrome (RLS)
A Randomized, Double-Blind, Placebo-Controlled Safety and Efficacy Study of IPX159 in the Treatment of Moderate to Severe Restless Legs Syndrome (RLS)
Status: Enrolling
Updated: 1/31/2017
Research Center of Southern California
mi
from
Oceanside, CA
Click here to add this to my saved trials
Safety and Efficacy Study of IPX159 in Restless Legs Syndrome (RLS)
A Randomized, Double-Blind, Placebo-Controlled Safety and Efficacy Study of IPX159 in the Treatment of Moderate to Severe Restless Legs Syndrome (RLS)
Status: Enrolling
Updated:  1/31/2017
Stanford Center for Human Sleep Research
mi
from
Redwood City, CA
Safety and Efficacy Study of IPX159 in Restless Legs Syndrome (RLS)
A Randomized, Double-Blind, Placebo-Controlled Safety and Efficacy Study of IPX159 in the Treatment of Moderate to Severe Restless Legs Syndrome (RLS)
Status: Enrolling
Updated: 1/31/2017
Stanford Center for Human Sleep Research
mi
from
Redwood City, CA
Click here to add this to my saved trials
Safety and Efficacy Study of IPX159 in Restless Legs Syndrome (RLS)
A Randomized, Double-Blind, Placebo-Controlled Safety and Efficacy Study of IPX159 in the Treatment of Moderate to Severe Restless Legs Syndrome (RLS)
Status: Enrolling
Updated:  1/31/2017
Neurological Research Institute
mi
from
Santa Monica, CA
Safety and Efficacy Study of IPX159 in Restless Legs Syndrome (RLS)
A Randomized, Double-Blind, Placebo-Controlled Safety and Efficacy Study of IPX159 in the Treatment of Moderate to Severe Restless Legs Syndrome (RLS)
Status: Enrolling
Updated: 1/31/2017
Neurological Research Institute
mi
from
Santa Monica, CA
Click here to add this to my saved trials
Safety and Efficacy Study of IPX159 in Restless Legs Syndrome (RLS)
A Randomized, Double-Blind, Placebo-Controlled Safety and Efficacy Study of IPX159 in the Treatment of Moderate to Severe Restless Legs Syndrome (RLS)
Status: Enrolling
Updated:  1/31/2017
Sleep-Alertness Disorder Center
mi
from
Aurora, CO
Safety and Efficacy Study of IPX159 in Restless Legs Syndrome (RLS)
A Randomized, Double-Blind, Placebo-Controlled Safety and Efficacy Study of IPX159 in the Treatment of Moderate to Severe Restless Legs Syndrome (RLS)
Status: Enrolling
Updated: 1/31/2017
Sleep-Alertness Disorder Center
mi
from
Aurora, CO
Click here to add this to my saved trials
Safety and Efficacy Study of IPX159 in Restless Legs Syndrome (RLS)
A Randomized, Double-Blind, Placebo-Controlled Safety and Efficacy Study of IPX159 in the Treatment of Moderate to Severe Restless Legs Syndrome (RLS)
Status: Enrolling
Updated:  1/31/2017
PAB Clinical Research
mi
from
Brandon, FL
Safety and Efficacy Study of IPX159 in Restless Legs Syndrome (RLS)
A Randomized, Double-Blind, Placebo-Controlled Safety and Efficacy Study of IPX159 in the Treatment of Moderate to Severe Restless Legs Syndrome (RLS)
Status: Enrolling
Updated: 1/31/2017
PAB Clinical Research
mi
from
Brandon, FL
Click here to add this to my saved trials
Safety and Efficacy Study of IPX159 in Restless Legs Syndrome (RLS)
A Randomized, Double-Blind, Placebo-Controlled Safety and Efficacy Study of IPX159 in the Treatment of Moderate to Severe Restless Legs Syndrome (RLS)
Status: Enrolling
Updated:  1/31/2017
MD Clinical
mi
from
Hallandale Beach, FL
Safety and Efficacy Study of IPX159 in Restless Legs Syndrome (RLS)
A Randomized, Double-Blind, Placebo-Controlled Safety and Efficacy Study of IPX159 in the Treatment of Moderate to Severe Restless Legs Syndrome (RLS)
Status: Enrolling
Updated: 1/31/2017
MD Clinical
mi
from
Hallandale Beach, FL
Click here to add this to my saved trials
Safety and Efficacy Study of IPX159 in Restless Legs Syndrome (RLS)
A Randomized, Double-Blind, Placebo-Controlled Safety and Efficacy Study of IPX159 in the Treatment of Moderate to Severe Restless Legs Syndrome (RLS)
Status: Enrolling
Updated:  1/31/2017
Neurology Associates of Ormond Beach
mi
from
Ormond Beach, FL
Safety and Efficacy Study of IPX159 in Restless Legs Syndrome (RLS)
A Randomized, Double-Blind, Placebo-Controlled Safety and Efficacy Study of IPX159 in the Treatment of Moderate to Severe Restless Legs Syndrome (RLS)
Status: Enrolling
Updated: 1/31/2017
Neurology Associates of Ormond Beach
mi
from
Ormond Beach, FL
Click here to add this to my saved trials
Safety and Efficacy Study of IPX159 in Restless Legs Syndrome (RLS)
A Randomized, Double-Blind, Placebo-Controlled Safety and Efficacy Study of IPX159 in the Treatment of Moderate to Severe Restless Legs Syndrome (RLS)
Status: Enrolling
Updated:  1/31/2017
Resurgence Group
mi
from
Palm Harbor, FL
Safety and Efficacy Study of IPX159 in Restless Legs Syndrome (RLS)
A Randomized, Double-Blind, Placebo-Controlled Safety and Efficacy Study of IPX159 in the Treatment of Moderate to Severe Restless Legs Syndrome (RLS)
Status: Enrolling
Updated: 1/31/2017
Resurgence Group
mi
from
Palm Harbor, FL
Click here to add this to my saved trials
Safety and Efficacy Study of IPX159 in Restless Legs Syndrome (RLS)
A Randomized, Double-Blind, Placebo-Controlled Safety and Efficacy Study of IPX159 in the Treatment of Moderate to Severe Restless Legs Syndrome (RLS)
Status: Enrolling
Updated:  1/31/2017
Neurotrials Research, Inc.
mi
from
Atlanta, GA
Safety and Efficacy Study of IPX159 in Restless Legs Syndrome (RLS)
A Randomized, Double-Blind, Placebo-Controlled Safety and Efficacy Study of IPX159 in the Treatment of Moderate to Severe Restless Legs Syndrome (RLS)
Status: Enrolling
Updated: 1/31/2017
Neurotrials Research, Inc.
mi
from
Atlanta, GA
Click here to add this to my saved trials
Safety and Efficacy Study of IPX159 in Restless Legs Syndrome (RLS)
A Randomized, Double-Blind, Placebo-Controlled Safety and Efficacy Study of IPX159 in the Treatment of Moderate to Severe Restless Legs Syndrome (RLS)
Status: Enrolling
Updated:  1/31/2017
Georgia Health Sciences University
mi
from
Augusta, GA
Safety and Efficacy Study of IPX159 in Restless Legs Syndrome (RLS)
A Randomized, Double-Blind, Placebo-Controlled Safety and Efficacy Study of IPX159 in the Treatment of Moderate to Severe Restless Legs Syndrome (RLS)
Status: Enrolling
Updated: 1/31/2017
Georgia Health Sciences University
mi
from
Augusta, GA
Click here to add this to my saved trials
Safety and Efficacy Study of IPX159 in Restless Legs Syndrome (RLS)
A Randomized, Double-Blind, Placebo-Controlled Safety and Efficacy Study of IPX159 in the Treatment of Moderate to Severe Restless Legs Syndrome (RLS)
Status: Enrolling
Updated:  1/31/2017
SleepMed of Central Georgia
mi
from
Macon, GA
Safety and Efficacy Study of IPX159 in Restless Legs Syndrome (RLS)
A Randomized, Double-Blind, Placebo-Controlled Safety and Efficacy Study of IPX159 in the Treatment of Moderate to Severe Restless Legs Syndrome (RLS)
Status: Enrolling
Updated: 1/31/2017
SleepMed of Central Georgia
mi
from
Macon, GA
Click here to add this to my saved trials
Safety and Efficacy Study of IPX159 in Restless Legs Syndrome (RLS)
A Randomized, Double-Blind, Placebo-Controlled Safety and Efficacy Study of IPX159 in the Treatment of Moderate to Severe Restless Legs Syndrome (RLS)
Status: Enrolling
Updated:  1/31/2017
University of Iowa Hospitals and Clinics
mi
from
Iowa City, IA
Safety and Efficacy Study of IPX159 in Restless Legs Syndrome (RLS)
A Randomized, Double-Blind, Placebo-Controlled Safety and Efficacy Study of IPX159 in the Treatment of Moderate to Severe Restless Legs Syndrome (RLS)
Status: Enrolling
Updated: 1/31/2017
University of Iowa Hospitals and Clinics
mi
from
Iowa City, IA
Click here to add this to my saved trials
Safety and Efficacy Study of IPX159 in Restless Legs Syndrome (RLS)
A Randomized, Double-Blind, Placebo-Controlled Safety and Efficacy Study of IPX159 in the Treatment of Moderate to Severe Restless Legs Syndrome (RLS)
Status: Enrolling
Updated:  1/31/2017
Community Research
mi
from
Crestview Hills, KY
Safety and Efficacy Study of IPX159 in Restless Legs Syndrome (RLS)
A Randomized, Double-Blind, Placebo-Controlled Safety and Efficacy Study of IPX159 in the Treatment of Moderate to Severe Restless Legs Syndrome (RLS)
Status: Enrolling
Updated: 1/31/2017
Community Research
mi
from
Crestview Hills, KY
Click here to add this to my saved trials
Safety and Efficacy Study of IPX159 in Restless Legs Syndrome (RLS)
A Randomized, Double-Blind, Placebo-Controlled Safety and Efficacy Study of IPX159 in the Treatment of Moderate to Severe Restless Legs Syndrome (RLS)
Status: Enrolling
Updated:  1/31/2017
Kentucky Research Group
mi
from
Louisville, KY
Safety and Efficacy Study of IPX159 in Restless Legs Syndrome (RLS)
A Randomized, Double-Blind, Placebo-Controlled Safety and Efficacy Study of IPX159 in the Treatment of Moderate to Severe Restless Legs Syndrome (RLS)
Status: Enrolling
Updated: 1/31/2017
Kentucky Research Group
mi
from
Louisville, KY
Click here to add this to my saved trials
Safety and Efficacy Study of IPX159 in Restless Legs Syndrome (RLS)
A Randomized, Double-Blind, Placebo-Controlled Safety and Efficacy Study of IPX159 in the Treatment of Moderate to Severe Restless Legs Syndrome (RLS)
Status: Enrolling
Updated:  1/31/2017
Johns Hopkins Bayview Medical Center Campus
mi
from
Baltimore, MD
Safety and Efficacy Study of IPX159 in Restless Legs Syndrome (RLS)
A Randomized, Double-Blind, Placebo-Controlled Safety and Efficacy Study of IPX159 in the Treatment of Moderate to Severe Restless Legs Syndrome (RLS)
Status: Enrolling
Updated: 1/31/2017
Johns Hopkins Bayview Medical Center Campus
mi
from
Baltimore, MD
Click here to add this to my saved trials
Safety and Efficacy Study of IPX159 in Restless Legs Syndrome (RLS)
A Randomized, Double-Blind, Placebo-Controlled Safety and Efficacy Study of IPX159 in the Treatment of Moderate to Severe Restless Legs Syndrome (RLS)
Status: Enrolling
Updated:  1/31/2017
Sleep Health Centers
mi
from
Brighton, MA
Safety and Efficacy Study of IPX159 in Restless Legs Syndrome (RLS)
A Randomized, Double-Blind, Placebo-Controlled Safety and Efficacy Study of IPX159 in the Treatment of Moderate to Severe Restless Legs Syndrome (RLS)
Status: Enrolling
Updated: 1/31/2017
Sleep Health Centers
mi
from
Brighton, MA
Click here to add this to my saved trials
Safety and Efficacy Study of IPX159 in Restless Legs Syndrome (RLS)
A Randomized, Double-Blind, Placebo-Controlled Safety and Efficacy Study of IPX159 in the Treatment of Moderate to Severe Restless Legs Syndrome (RLS)
Status: Enrolling
Updated:  1/31/2017
Beacon Clinical Research, LLC
mi
from
Brockton, MA
Safety and Efficacy Study of IPX159 in Restless Legs Syndrome (RLS)
A Randomized, Double-Blind, Placebo-Controlled Safety and Efficacy Study of IPX159 in the Treatment of Moderate to Severe Restless Legs Syndrome (RLS)
Status: Enrolling
Updated: 1/31/2017
Beacon Clinical Research, LLC
mi
from
Brockton, MA
Click here to add this to my saved trials
Safety and Efficacy Study of IPX159 in Restless Legs Syndrome (RLS)
A Randomized, Double-Blind, Placebo-Controlled Safety and Efficacy Study of IPX159 in the Treatment of Moderate to Severe Restless Legs Syndrome (RLS)
Status: Enrolling
Updated:  1/31/2017
QUEST Research Institute
mi
from
Farmington Hills, MI
Safety and Efficacy Study of IPX159 in Restless Legs Syndrome (RLS)
A Randomized, Double-Blind, Placebo-Controlled Safety and Efficacy Study of IPX159 in the Treatment of Moderate to Severe Restless Legs Syndrome (RLS)
Status: Enrolling
Updated: 1/31/2017
QUEST Research Institute
mi
from
Farmington Hills, MI
Click here to add this to my saved trials
Safety and Efficacy Study of IPX159 in Restless Legs Syndrome (RLS)
A Randomized, Double-Blind, Placebo-Controlled Safety and Efficacy Study of IPX159 in the Treatment of Moderate to Severe Restless Legs Syndrome (RLS)
Status: Enrolling
Updated:  1/31/2017
Global Medical Institutes, Llc
mi
from
Princeton, NJ
Safety and Efficacy Study of IPX159 in Restless Legs Syndrome (RLS)
A Randomized, Double-Blind, Placebo-Controlled Safety and Efficacy Study of IPX159 in the Treatment of Moderate to Severe Restless Legs Syndrome (RLS)
Status: Enrolling
Updated: 1/31/2017
Global Medical Institutes, Llc
mi
from
Princeton, NJ
Click here to add this to my saved trials
Safety and Efficacy Study of IPX159 in Restless Legs Syndrome (RLS)
A Randomized, Double-Blind, Placebo-Controlled Safety and Efficacy Study of IPX159 in the Treatment of Moderate to Severe Restless Legs Syndrome (RLS)
Status: Enrolling
Updated:  1/31/2017
Fieve Clinical Research
mi
from
New York, NY
Safety and Efficacy Study of IPX159 in Restless Legs Syndrome (RLS)
A Randomized, Double-Blind, Placebo-Controlled Safety and Efficacy Study of IPX159 in the Treatment of Moderate to Severe Restless Legs Syndrome (RLS)
Status: Enrolling
Updated: 1/31/2017
Fieve Clinical Research
mi
from
New York, NY
Click here to add this to my saved trials
Safety and Efficacy Study of IPX159 in Restless Legs Syndrome (RLS)
A Randomized, Double-Blind, Placebo-Controlled Safety and Efficacy Study of IPX159 in the Treatment of Moderate to Severe Restless Legs Syndrome (RLS)
Status: Enrolling
Updated:  1/31/2017
Comprehensive Multiple Sclerosis Care Center
mi
from
Patchogue, NY
Safety and Efficacy Study of IPX159 in Restless Legs Syndrome (RLS)
A Randomized, Double-Blind, Placebo-Controlled Safety and Efficacy Study of IPX159 in the Treatment of Moderate to Severe Restless Legs Syndrome (RLS)
Status: Enrolling
Updated: 1/31/2017
Comprehensive Multiple Sclerosis Care Center
mi
from
Patchogue, NY
Click here to add this to my saved trials
Safety and Efficacy Study of IPX159 in Restless Legs Syndrome (RLS)
A Randomized, Double-Blind, Placebo-Controlled Safety and Efficacy Study of IPX159 in the Treatment of Moderate to Severe Restless Legs Syndrome (RLS)
Status: Enrolling
Updated:  1/31/2017
Raleigh Neurology Associates
mi
from
Raleigh, NC
Safety and Efficacy Study of IPX159 in Restless Legs Syndrome (RLS)
A Randomized, Double-Blind, Placebo-Controlled Safety and Efficacy Study of IPX159 in the Treatment of Moderate to Severe Restless Legs Syndrome (RLS)
Status: Enrolling
Updated: 1/31/2017
Raleigh Neurology Associates
mi
from
Raleigh, NC
Click here to add this to my saved trials
Safety and Efficacy Study of IPX159 in Restless Legs Syndrome (RLS)
A Randomized, Double-Blind, Placebo-Controlled Safety and Efficacy Study of IPX159 in the Treatment of Moderate to Severe Restless Legs Syndrome (RLS)
Status: Enrolling
Updated:  1/31/2017
Wake Research Associates, LLC
mi
from
Raleigh, NC
Safety and Efficacy Study of IPX159 in Restless Legs Syndrome (RLS)
A Randomized, Double-Blind, Placebo-Controlled Safety and Efficacy Study of IPX159 in the Treatment of Moderate to Severe Restless Legs Syndrome (RLS)
Status: Enrolling
Updated: 1/31/2017
Wake Research Associates, LLC
mi
from
Raleigh, NC
Click here to add this to my saved trials